TardiMed Sciences LLC 4
4 · Timber Pharmaceuticals, Inc. · Filed Sep 16, 2020
Insider Transaction Report
Form 4
TardiMed Sciences LLC
10% Owner
Transactions
- Sale
Common Stock, par value $0.001 per share
2020-09-14$1.03/sh−455$469→ 5,625,271 total - Sale
Common Stock, par value $0.001 per share
2020-09-16$1.03/sh−100,694$103,695→ 5,437,517 total - Sale
Common Stock, par value $0.001 per share
2020-09-15$1.03/sh−87,060$89,550→ 5,538,211 total
Footnotes (2)
- [F1]The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $1.0200 to $1.0400, inclusive. The reporting person undertakes to provide to Timber Pharmaceuticals, Inc. ("Timber"), any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F2]The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $1.0200 to $ 1.0500, inclusive. The reporting person undertakes to provide to Timber, any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.